Abstract: Pinato prognostic nutritional index (PNI) adequately predicts long-term outcomes of various malignancies. However, its value in predicting outcomes in laryngeal squamous cell carcinoma (LSCC) is unknown.
INTRODUCTION

I
n 2012, 157,000 new cases of laryngeal cancer were diagnosed in the worldwide, with 138,000 and 19,000 new cases diagnosed in men and women, respectively. 1 Despite marked advances in surgery and radiotherapy over the past decades, the 5-year survival rates of patients with laryngeal squamous cell carcinoma (LSCC) have actually decreased in the recent years, from 57.1% to 51.9% in the United States. 2 Thus, assessing the prognostic factors in LSCC has become increasingly important.
Outcomes of LSCC patients are currently, if inaccurately, predicted from clinicopathological characteristics, such as primary tumor, regional node, distant metastasis (the tumornode-metastasis [TNM] components), or the stage, depth of invasion, and differentiation grade of the cancer. Although advances in molecular and cellular biology may lead to the discovery of new biomarkers and new therapeutic targets, the lack of standardization, regional availability, and need for further validation currently limit the routine clinical application of these biomarkers. 3 Therefore, clinical characteristics that predict survival are still needed.
Pretreatment nutritional and immunological status has been associated with long-term outcomes in patients with malignant tumors. 4, 5 Nutritional impairment is correlated with poor performance status, shorter survival, and increased mortality in patients with cancer. 6, 7 The prognostic nutritional index (PNI) is a score calculated from serum albumin concentration and total lymphocyte count in the peripheral blood. Increasing evidence shows that PNI scores adequately predict long-term outcomes of various malignancies. [8] [9] [10] [11] However, the prognostic value of the PNI in patients with LSCC is unknown.
As nutritional and immunological status is associated with LSCC prognosis, we hypothesized that the preoperative PNI scores might predict outcomes of patients with this disease. Here, we report the results of a large retrospective study in which preoperative PNI scores predicted long-term outcomes in patients with LSCC who had undergone curative laryngectomy.
METHODS
The institutional review board of the Sun Yat-sen University Cancer Center approved the study. All data were kept anonymous and confidential and were aggregated for analysis.
Patient Selection
We retrospectively analyzed patients who underwent laryngectomy as a 1st curative treatment option for LSCC between January 1, 1990 and July 31, 2010 at the Sun Yat-sen University Cancer Center, Guangzhou, China. All patients had histopathologically proven LSCC without distant metastasis and underwent curative laryngectomy. None had a history of adjuvant or neo-adjuvant therapy or other malignancies. Patients were contacted by telephone every 3 months during the 1st 2 years after surgery and every 6 months thereafter until death.
Study Variables
Patient age, sex, smoking status (never or ever smoker), drinking status (never or ever consumer of alcohol), tumor subsite, tumor stage (T stage), N stage, TNM stage, neck dissection (present or absent), pathological differentiation (poor, moderate, and high), and type of surgery (partial or total laryngectomy) were retrieved from the medical records. The conventional TNM system for laryngeal cancer established by the Union for International Cancer Control and the American Joint Committee on Cancer was used to stage tumors. 12 Laboratory data, including the serum albumin concentrations and lymphocyte count used to calculate the PNI, were obtained during preoperative examination. We have no reason to believe that the changes in analytic instruments varied markedly over the period described. Quality assurance protocols were run daily according to the Westgard Rules.
The PNI was calculated from preoperative values as
Cancer-specific survival (CSS) was defined as the time in months from the date of the surgery until death from cancerrelated causes. Overall survival (OS) was defined as the time in months from the date of surgery until death from any cause during the follow-up period.
Statistical Methods
The optimal cut-off PNI scores were determined with the Cutoff Finder software program, an R software-engineered, web-based system designed by Budczies et al 13 (http:// molpath.charite.de/cutoff/). The PNI cut-off value for 2 groups was 44.25, which had a specificity of only 10.4%. We then divided the patients into 3 groups based on their PNI scores: patients in whom the test was 70% sensitive (the high-probability of survival group), patients in whom the test was 70% specific (the low-probability of survival group), and patients in whom the test was equivocal (the mid-probability of survival group).
Categorical variables are reported as counts and percentages and were compared using Chi-square or Fisher exact tests. Univariate and multivariate analyses for survival difference were performed using Cox proportional hazards models and were expressed as hazard ratios and 95% confidence intervals. The variables that were shown to be associated with CSS and OS in the univariate analysis were evaluated in the multivariate Cox proportional hazard model. The likelihood ratios forward stepwise method was used for the multivariate Cox proportional analysis. Survival curves were calculated using the Kaplan-Meier method and compared using the log-rank test. All analyses were performed using IBM SPSS statistics software, version 20.0 (SPSS, Inc., Chicago, IL). Twotailed P values < 0.05 were considered significant.
RESULTS
Patient Characteristics
Of 1010 patients identified in the records, 35 with incomplete preoperative laboratory data were excluded, leaving 975 patients (948 men) in the analysis (Table 1) . Median follow-up (from the day of surgery to death or final follow-up call) was 83 months (range 0.3-300 months). Median (range) age was 60 (22-87) years. Almost 90% of patients were smokers, and 36% had a history of alcohol intake. Of primary tumors, two-thirds were in the glottis larynx and one-third was in the supraglottic larynx. About half the tumors were T1-2 and half in T3-4. About 20% of patients had lymph node metastasis. For cancer stage, about half the patients were initially diagnosed as early stage and about half as advanced stage.
Preoperative Nutritional Index Diagnostic Cut-Off Scores
The optimal cut-off PNI scores for predicting survival were determined to be 48.65 and 56.93 ( Figure 1 ). The level of 48.65 and 56.93 were defined as the cut-off values for CSS and OS in our study. Thus, we classified the patients into 3 groups: those with PNI scores of up to 48.65 (n ¼ 203; 20.8%; the low-probability of survival group), between 48.65 and 56.93 (n ¼ 515; 52.8%; the mid-probability of survival group), and those with scores greater than 56.93 (n ¼ 257; 26.4%; the high-probability of survival group). The 3 groups did not differ significantly except for age (P < 0.001), T stage (P ¼ 0.020), TNM stage (P ¼ 0.006), and type of laryngectomy (P ¼ 0.02; x 2 -test).
Univariate and Multivariate Analysis of Prognostic Factors
In univariate analyses, age, history of alcohol intake, tumor subsite, T stage, N stage, TNM stage, pathological differentiation, neck dissection, PNI score, and type of surgery were significant predictors of CSS and OS (Tables 2 and 3 Cut-off points for Preoperative Nutritional Index scores predicting survival for patients with laryngeal squamous cell carcinoma undergoing curative laryngectomy. Scores were set at hazard ratios providing a sensitivity of 70% and a specificity of 70%: scores less than 48.65 (n ¼ 203; 20.8%) indicated a low probability of cancer-specific survival, scores between 48.65 and 56.93 (n ¼ 515; 52.8%), a moderate probability of cancer-specific survival; and scores greater than 56.93 (n ¼ 257; 26.4%), a high probability of cancer-specific survival.
<48.65 [low probability]; HR, 0.66; 95% CI, 0.50-0.87; P < 0.001) remained significant independent predictors of CSS (Table 3) .
Analysis of Cancer-Specific Survival and Prognostic Factors
Overall, 5-and 10-year CSS rates were 70.8% and 59.6%, respectively. The 5-year CSS rate was 57.3% in the lowprobability group, 72.8% in the mid-probability group, and 77.6% in the high-probability group. The 10-year CSS rates were 44.2%, 61.6%, and 68.3%, respectively (P < 0.001; Figure 2 ). During follow-up, 112 patients (55.2%) in the low-probability group, 186 (36.1%) in the mid-probability group, and 78 (30.4%) in the high-probability group died of tumor-related causes (P < 0.001; Figure 3) .
Overall, the 5-and the 10-year OS rates were 69.3% and 55.0%, respectively. The 5-year OS rate was 56.6% in the lowprobability group, 71.3% in the mid-probability group, and 75.3% in the high-probability group. The 10-year OS rates were 42.7%, 55.6%, and 63.5%, respectively (P < 0.001; Figure 4 ).
DISCUSSION
We used the Cutoff Finder software program to determine the optimal PNI scores for predicting cancer survival. The 
Ã According to the 7th American Joint Committee on Cancer staging system.
preoperative PNI groups predicted long-term outcome of LSCC, independent of age, history of alcohol intake, T stage, and N stage. The low-probability group had a significantly lower CSS and OS rate and more often died of tumor-related causes than the other 2 groups. Two important factors characterize head and neck cancer patients: malnutrition and immunosuppression.
14 Clinically, most laboratory assessments could reflect both malnutrition and immunosuppression, but they are not ideal because they are inaccurate, insensitive, or inconvenient to perform. However, albumin is a widely used indicator of nutrition and the host's inflammatory reaction, whereas lymphocytes are key elements of the immune system. 4, 11 The PNI, a prognostic score based on lymphocyte count and albumin levels, was first used to assess the immunological and nutritional aspects of patients undergoing surgery of the gastrointestinal tract, predominantly as an indicator of the nutritional status of any given patient. 15 Nutritional status has recently been linked to the prognosis of various cancer types. 8, [16] [17] [18] A low PNI indicates lower in albumin concentrations, lymphocyte counts, or both. The presence of cancer cachexia, partly reflected by a lower albumin concentration, is driven by a sustained inflammatory response, either from the tumor itself or as a host reaction. 19 Albumin is an objective measure often used in clinical studies to reflect malnutrition in the patient. On one hand, in some studies, malnutrition prolonged hospital stay, 20, 21 increased the number of medical complications, 22 and sometimes increased the death rate. 22, 23 Furthermore, ecological and observational studies suggest that low serum albumin concentration is associated with higher mortality from cancer. [24] [25] [26] Albumin is important in assessing malnutrition, indicating that these nutritional assessments identify different at-risk groups.
On the other hand, malnutrition impairs host immunity. 27 Patients with tumors have decreased host immunity that nearly always worsens coexisting malnutrition, and the outcomes of decreased host immunity maybe more dangerous in a malnourished host than in a well-nourished one.
On the other hand, lymphocytes are involved in cytotoxic cell death and cytokine production, which inhibit the proliferation and metastatic capacity of tumor cells by starting an immune response against the tumor.
28 Cytotoxic T Lymphocytes (CTL) induce apoptosis of cancer cells and inhibit tumor growth, whereas CD8þ T lymphocyte infiltration is associated with better overall patient outcomes. Furthermore, immunologic mediators (such as IL-10 and transforming growth factor-b) are released, which can have a marked immunosuppressive effect with consequent impaired lymphocyte function and reduced lymphocyte counts. 29 Thus, a low lymphocyte count is associated with an immunosuppressed condition, suggesting that the host has an insufficient antitumor immunological reaction. 30 Thus, albumin concentrations and lymphocyte counts, taken together, may indicate chronic inflammation, immunity, and nutritional status, all of which are of prognostic value. Malnutrition and immunosuppression are often problems in elderly surgical patients. Among our patients, 71.4% (145/ 203) of those with a low-probability of survival (PNI scores <48.65) were 60 years old or older, whereas only 37.7% (97/ 257) of those with a high-probability of survival (PNI scores >56.93) were 60 years old or older. Thus, the overall prevalence of malnutrition and immunosuppression was indeed higher among our elderly patients.
We found that PNI score was also related to T stage and TNM stage. Further, advanced T stage (T3-4) and advanced TNM stage (TNM III-IV) patients were preferentially treated with total laryngectomy. 2 The TNM stage comprises the effects of T and N stages, which generally reflects the prominent impact of local invasion of LSCC and cervical lymph node metastasis on prognosis. More than 60% of our patients with TNM III-IV stage disease were in the low-probability-ofsurvival group. These patients were also more likely to experience malnutrition and immunosuppression.
Various PNI cut-off scores selected with different methods have been used in different cancers. 5, 11, 31 The cut-off score is usually set at 45, which is defined as moderate-to-severe malnutrition. 31 Yao et al 32 showed that a cut-off score of 44.6 predicted reduced survival. Hong et al 11 used 52.48 and found the same result.
However, the optimal PNI cut-off score for predicting the long-term outcomes of LSCC remains unclear. In the present study, the optimal PNI cut-off scores were determined to be 48.65 and 56.93 by the Cutoff Finder software program. Based on these cut-off values, we classified the patients into 3 groups according to their PNI scores: below 48.65, between 48.65 and 56.93, and above 56.93. CSS was lower in patients with PNI scores less than 48.65 than it was in those with PNI scores between 48.65 and 56.93 and in those with PNI greater than 56.93 (5-year CSS, 57.3% vs 72.8% and 77.6%, respectively; 10-year CSS, 44.2% vs 61.6% and 68.3%, respectively; log-rank test, P < 0.001). OS was lower in patients with PNI scores less than 48.65 than it was in those with PNI scores between 48.65 and 56.93 and in those with PNI greater than 56.93 (5-year OS, 56.6% vs 71.3% and 75.3%, respectively; 10-year OS, 42.7% vs 55.6% and 63.5%, respectively; log-rank test, P < 0.001).
Limitations of the Study
It is a retrospective, single-institution observational study based on only 975 patients. A prospective study would provide a better evaluation of prognostic factors and would allow serial PNI scores to be obtained so that they could be correlated with declines in other clinical variables. Hence, these analyses need to be validated in a larger cohort of patients.
CONCLUSIONS
Although our results warrant further validation in independent prospective studies, we found that the PNI is a simple, reproducible, inexpensive, and reliable measure of systemic inflammation response. In our study, the PNI score significantly predicted CSS and OS. Therefore, we suggest that the PNI should be included in the routine assessment of LSCC patients.
